Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG).
Durrant
K R
KR
Department of Radiotherapy and Oncology, Churchill Hospital, Headington, Oxford, United Kingdom.
Mangioni
C
C
Lacave
A J
AJ
George
M
M
van der Burg
M E
ME
Guthrie
D
D
Rotmenz
N
N
Dalesio
O
O
Vermorken
J B
JB
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage; D008171:Lung Diseases / Q000139:chemically induced; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D014846:Vulvar Neoplasms / Q000188:drug therapy*
D001761:Bleomycin; D008130:Lomustine; D008727:Methotrexate